Literature DB >> 14638598

Normal p50 gating in unmedicated schizophrenia outpatients.

Sidse M Arnfred1, Andrew C N Chen, Birte Y Glenthøj, Ralf P Hemmingsen.   

Abstract

OBJECTIVE: The hypothesis of a sensory gating defect in schizophrenia has been supported by studies demonstrating deficient auditory P50 gating in patients. P50 gating is the relative attenuation of P50 amplitude in the auditory evoked potential following the second auditory stimulus of a stimulus pair.
METHOD: Auditory evoked potentials of 12 unmedicated male patients with schizophrenia and 24 healthy men were recorded during three runs of 40 click pairs. Three alternative waveform-processing strategies were used to analyze the data.
RESULTS: Regardless of strategy used, the differences between subject groups regarding P50 amplitude and gating were nonsignificant.
CONCLUSIONS: The P50 gating in the patient group was normal. The results do not support the concept of the P50 gating defect as a general trait marker of schizophrenia.

Entities:  

Mesh:

Year:  2003        PMID: 14638598     DOI: 10.1176/appi.ajp.160.12.2236

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  17 in total

1.  Towards a functional topography of sensory gating areas: invasive P50 recording and electrical stimulation mapping in epilepsy surgery candidates.

Authors:  Martin Kurthen; Peter Trautner; Timm Rosburg; Thomas Grunwald; Thomas Dietl; Kai-Uwe Kühn; Carlo Schaller; Christian E Elger; Horst Urbach; Kost Elisevich; Nash N Boutros
Journal:  Psychiatry Res       Date:  2007-05-21       Impact factor: 3.222

2.  Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.

Authors:  Signe Düring; Birte Y Glenthøj; Gitte Saltoft Andersen; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2014-07-23       Impact factor: 7.853

3.  Auditory sensory gating in young adolescents with early-onset psychosis: a comparison with attention deficit/hyperactivity disorder.

Authors:  Cecilie Koldbæk Lemvigh; Jens Richardt Møllegaard Jepsen; Birgitte Fagerlund; Anne Katrine Pagsberg; Birte Yding Glenthøj; Jacob Rydkjær; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2019-10-24       Impact factor: 7.853

4.  P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment.

Authors:  Bob Oranje; Bodil Aggernaes; Hans Rasmussen; Bjorn H Ebdrup; Birte Y Glenthøj
Journal:  Schizophr Bull       Date:  2012-01-12       Impact factor: 9.306

5.  Critical evaluation of auditory event-related potential deficits in schizophrenia: evidence from large-scale single-subject pattern classification.

Authors:  Andres H Neuhaus; Florin C Popescu; Johannes Rentzsch; Jürgen Gallinat
Journal:  Schizophr Bull       Date:  2013-10-22       Impact factor: 9.306

6.  Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating.

Authors:  Boris B Quednow; Jürgen Brinkmeyer; Arian Mobascher; Michael Nothnagel; Francesco Musso; Gerhard Gründer; Noah Savary; Nadine Petrovsky; Ingo Frommann; Leonhard Lennertz; Katja N Spreckelmeyer; Thomas F Wienker; Norbert Dahmen; Norbert Thuerauf; Marion Clepce; Falk Kiefer; Tomislav Majic; Rainald Mössner; Wolfgang Maier; Jürgen Gallinat; Amalia Diaz-Lacava; Mohammad R Toliat; Holger Thiele; Peter Nürnberg; Michael Wagner; Georg Winterer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

7.  Sensory gating endophenotype based on its neural oscillatory pattern and heritability estimate.

Authors:  L Elliot Hong; Ann Summerfelt; Braxton D Mitchell; Robert P McMahon; Ikwunga Wonodi; Robert W Buchanan; Gunvant K Thaker
Journal:  Arch Gen Psychiatry       Date:  2008-09

Review 8.  Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia.

Authors:  Randal G Ross; Karen E Stevens; William R Proctor; Sherry Leonard; Michael A Kisley; Sharon K Hunter; Robert Freedman; Catherine E Adams
Journal:  J Child Psychol Psychiatry       Date:  2009-11-18       Impact factor: 8.982

9.  Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.

Authors:  L Elliot Hong; Ann Summerfelt; Robert W Buchanan; Patricio O'Donnell; Gunvant K Thaker; Martin A Weiler; Adrienne C Lahti
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

10.  Diagnostic specificity of neurophysiological endophenotypes in schizophrenia and bipolar disorder.

Authors:  Jason K Johannesen; Brian F O'Donnell; Anantha Shekhar; John H McGrew; William P Hetrick
Journal:  Schizophr Bull       Date:  2012-08-27       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.